Published in Clin Infect Dis on April 01, 1999
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis (2009) 2.09
Clinical uses of intravenous immunoglobulin. Clin Exp Immunol (2005) 1.61
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol (2007) 1.57
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Current concepts in the management of necrotizing fasciitis. Front Surg (2014) 1.45
General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42
Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR. Microbiology (2006) 1.42
egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun (2004) 1.41
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry (2006) 1.33
TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30
Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J (2011) 1.29
Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg (2014) 1.10
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother (2001) 1.05
Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J (2007) 1.03
Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis (2014) 1.02
Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerg Microbes Infect (2012) 1.01
Group A Streptococcal Sepsis. Curr Infect Dis Rep (2003) 1.00
The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis. Crit Care (2011) 0.99
Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect Immun (2010) 0.99
One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis (2008) 0.98
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response. PLoS Pathog (2008) 0.98
A five-year review of necrotising fasciitis in a tertiary referral unit. Ann R Coll Surg Engl (2013) 0.97
Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India. J Clin Microbiol (2012) 0.94
A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol (2007) 0.91
Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease. Indian J Crit Care Med (2012) 0.91
Combination antibiotic therapy for community-acquired pneumonia. Ann Intensive Care (2011) 0.91
Lack of muco-cutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma. Clin Exp Immunol (2002) 0.90
A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes. Clin Vaccine Immunol (2010) 0.90
Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. Am J Pathol (2011) 0.89
Superantigen antagonist peptides. Crit Care (2001) 0.86
Primary group A streptococcal septic shock syndrome simulating perforated appendicitis in a previously healthy girl. BMJ Case Rep (2013) 0.86
Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One (2011) 0.86
Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt) (2014) 0.85
Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality. PLoS One (2014) 0.83
Therapeutic Approaches to Streptococcal Toxic Shock Syndrome. Curr Infect Dis Rep (1999) 0.83
Necrotizing Soft Tissue Infections. Curr Infect Dis Rep (2003) 0.82
Necrotizing fasciitis. Eplasty (2014) 0.81
Fulminant toxic shock syndrome following rituximab therapy in an 11-year-old boy. J Neurol (2013) 0.81
Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain. Clin Vaccine Immunol (2009) 0.81
Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis. Trans Am Ophthalmol Soc (2004) 0.80
The Treatment of Severe Group A Streptococcal Infections. Curr Infect Dis Rep (2003) 0.80
Necrotizing fasciitis resulting from human bites: A report of two cases of disease caused by group A streptococcus. Can J Infect Dis Med Microbiol (2005) 0.80
Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med (2017) 0.80
Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells. Proc Natl Acad Sci U S A (2017) 0.79
Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome. BMC Immunol (2014) 0.79
Flesh-eating disease: A note on necrotizing fasciitis. Can J Infect Dis (2001) 0.78
Necrotizing fasciitis complicating pregnancy: a case report and literature review. Case Rep Obstet Gynecol (2014) 0.78
Infectious shock and toxic shock syndrome diagnoses in hospitals, Colorado, USA. Emerg Infect Dis (2013) 0.78
Group A streptococcal toxic shock syndrome developing in the third trimester of pregnancy. Infect Dis Obstet Gynecol (2002) 0.77
Intravenous immunoglobulin in necrotizing fasciitis - A case report and review of recent literature. Ann Med Surg (Lond) (2015) 0.76
Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity. Med Microbiol Immunol (2005) 0.76
Septic Shock and Toxic Shock: Do Adjunctive Therapies Improve Outcome? Curr Infect Dis Rep (1999) 0.76
Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units. Eur J Pediatr (2010) 0.76
Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study. Sci Rep (2017) 0.75
Editorial commentary: step on the GAS: are we almost there for clindamycin and intravenous immunoglobulin? Clin Infect Dis (2014) 0.75
Flesh-eating disease: A note on necrotizing fasciitis. Paediatr Child Health (2001) 0.75
Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock. J Intensive Care (2013) 0.75
Sensitive, Rapid, Quantitative and in Vitro Method for the Detection of Biologically Active Staphylococcal Enterotoxin Type E. Toxins (Basel) (2016) 0.75
Purpura fulminans caused by meningococcemia in an infant. BMJ Case Rep (2013) 0.75
Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults. Can J Infect Dis (2002) 0.75
Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ Open Respir Res (2016) 0.75
Dynamics of the immune response against extracellular products of group A streptococci during infection. Clin Vaccine Immunol (2006) 0.75
Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. Surg Infect (Larchmt) (2017) 0.75
Toxic shock syndrome related to Streptococcus equi subsp zooepidemicus. BMJ Case Rep (2013) 0.75
Case 1: Pneumonia with hypotension and a rash. Paediatr Child Health (2004) 0.75
Refractory Toxic Shock-Like Syndrome from Streptococcus dysgalactiae ssp. equisimilis and Intravenous Immunoglobulin as Salvage Therapy: A Case Series. Case Rep Infect Dis (2016) 0.75
Agents to reduce cytokine storm. F1000Res (2016) 0.75
Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom. Emerg Infect Dis (2017) 0.75
Therapeutic targets in necrotizing soft tissue infections. Intensive Care Med (2017) 0.75
Shocking superantigens promote establishment of bacterial infection. Proc Natl Acad Sci U S A (2017) 0.75
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
The receptor for the cytotoxic ligand TRAIL. Science (1997) 6.39
Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med (1992) 6.29
The maintenance of key pecking by stimulus-contingent and response-independent food presentation. J Exp Anal Behav (1973) 6.12
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Meta-analysis in clinical research. Ann Intern Med (1987) 5.16
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell (2000) 4.19
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem (1996) 3.97
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics (2001) 3.83
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72
Two different kinds of key peck in the pigeon: some properties of responses maintained by negative and positive response-reinforcer contingencies. J Exp Anal Behav (1972) 3.57
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53
The role of the response-reinforcer contingency in negative automaintenance. J Exp Anal Behav (1972) 3.52
Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science (1997) 3.51
A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ (1998) 3.46
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician (1997) 3.29
Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA (1998) 3.28
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.19
A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem (1994) 3.13
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
Effects of reinforcement magnitude on pigeons' preference for different fixed-ratio schedules of reinforcement. J Exp Anal Behav (1969) 3.04
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ (2001) 2.99
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology (1989) 2.88
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (1996) 2.87
Development of complex, stereotyped behavior in pigeons. J Exp Anal Behav (1980) 2.85
Role of CED-4 in the activation of CED-3. Nature (1997) 2.76
The social psychology of the gift. AJS (1967) 2.63
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol (1997) 2.55
Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer (2005) 2.49
Discriminative stimulus location as a determinant of positive and negative behavioral contrast in the pigeon. J Exp Anal Behav (1975) 2.47
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Maintenance of key pecking by response-independent food presentation: the role of the modality of the signal for food. J Exp Anal Behav (1973) 2.42
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics (1999) 2.34
Photogrammetric measurement of nerve fiber layer thickness. Ophthalmology (1989) 2.34
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Discrete-trials spaced responding in the pigeon: the dependence of efficient performance on the availability of a stimulus for collateral pecking. J Exp Anal Behav (1971) 2.31
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem (1998) 2.25
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother (2000) 2.22
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol (1999) 2.19
Behavioral contrast in the pigeon: a study of the duration of key pecking maintained on multiple schedules of reinforcement. J Exp Anal Behav (1975) 2.19
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
A randomized crossover trial of Quick Medical Reference (QMR) as a teaching tool for medical interns. J Gen Intern Med (1994) 2.10
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10